Kane W H, Devore-Carter D, Ortel T L
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Biochemistry. 1990 Jul 24;29(29):6762-8. doi: 10.1021/bi00481a003.
Human coagulation factor V is a protein cofactor that is an essential component of the prothrombinase complex. A full-length factor V cDNA has been subcloned into the mammalian expression vector pDX and used to transfect COS cells. Approximately 95 +/- 4% of the recombinant human factor V (rHFV) synthesized in COS cells is secreted into the culture medium. Forty-eight hours after transfection rHFV antigen levels in the conditioned medium were 70 +/- 15 ng/mL. Factor V activity determined by fibrometer assay increased approximately 5-fold from 0.027 +/- 0.012 to 0.124 +/- 0.044 unit/mL following activation by the factor V activating enzyme from Russell's viper venom (RVV-V). A chromogenic assay specific for factor Va indicated that recombinant factor V had 3.8 +/- 1.3% of the activity of the activated protein. The estimated specific activity of the recombinant factor Va was approximately 1800 +/- 500 units/mg, which is similar to the specific activity of purified plasma factor Va of 1700-2000 units/mg. Immunoprecipitation of [35S]methionine-labeled rHFV revealed a single high molecular mass component (approximately 330 kDa). Treatment of rHFV with thrombin or RVV-V resulted in the formation of proteolytic products that were similar to those seen with plasma factor V. We have also expressed a mutant, rHFV-des-B811-1441, that lacks a large portion of the highly glycosylated connecting region that is present in factor V. Immunoprecipitation of [35S]methionine-labeled rHFV-des-B811-1441 revealed a single-chain polypeptide with Mr approximately 230 kDa. This mutant constitutively expressed 38 +/- 7% of the activity of the RVV-V-activated protein.(ABSTRACT TRUNCATED AT 250 WORDS)
人凝血因子V是一种蛋白质辅因子,是凝血酶原酶复合物的重要组成部分。全长因子V cDNA已亚克隆到哺乳动物表达载体pDX中,并用于转染COS细胞。在COS细胞中合成的重组人因子V(rHFV)约95±4%分泌到培养基中。转染48小时后,条件培养基中的rHFV抗原水平为70±15 ng/mL。用纤维蛋白原测定仪测定,经罗素蝰蛇毒(RVV-V)中的因子V激活酶激活后,因子V活性从0.027±0.012单位/mL增加到0.124±0.044单位/mL,约增加了5倍。针对因子Va的显色测定表明,重组因子V具有活化蛋白活性的3.8±1.3%。重组因子Va的估计比活性约为1800±500单位/mg,与纯化血浆因子Va的比活性1700 - 2000单位/mg相似。对[35S]甲硫氨酸标记的rHFV进行免疫沉淀,显示出单一的高分子量成分(约330 kDa)。用凝血酶或RVV-V处理rHFV导致形成蛋白水解产物,与血浆因子V的情况相似。我们还表达了一种突变体rHFV-des-B811-1441,它缺少因子V中存在的大部分高度糖基化连接区。对[35S]甲硫氨酸标记的rHFV-des-B811-1441进行免疫沉淀,显示出一条Mr约为230 kDa的单链多肽。该突变体组成性表达RVV-V激活蛋白活性的38±7%。(摘要截短于250字)